K. G. KOHLSTAEDT, M.D.; IRVINE H. PAGE, M.D.
Several communications dealing with the clinical applications of sulfapyridine (2 sulfanyl-amino-pyridine) have appeared since Whitby's (1938) report of its value in the control of pneumococcic infections in mice. Among the first of these and one of great importance, is that of Evans and Gaisford (1938), which gave hope that a drug of value had been discovered. Subsequent work is confirming this belief.
The purpose of this communication is to describe our experience in the treatment of pneumococcic pneumonia in the Indianapolis City Hospital and in the private pavillion of the Methodist Hospital during the fall and winter of 1938-1939.
KOHLSTAEDT KG, PAGE IH. THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH SULFAPYRIDINE(THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH SULFAPYRIDINE*). Ann Intern Med. 1940;14:129–145. doi: 10.7326/0003-4819-14-1-129
Download citation file:
Published: Ann Intern Med. 1940;14(1):129-145.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use